NDC 68788-6399

Famotidine

Famotidine

Famotidine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Famotidine.

Product ID68788-6399_9e7232b5-6702-4c82-a217-0a85934c1752
NDC68788-6399
Product TypeHuman Prescription Drug
Proprietary NameFamotidine
Generic NameFamotidine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2016-05-31
Marketing CategoryANDA / ANDA
Application NumberANDA075511
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameFAMOTIDINE
Active Ingredient Strength20 mg/1
Pharm ClassesHistamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68788-6399-1

100 TABLET, FILM COATED in 1 BOTTLE (68788-6399-1)
Marketing Start Date2016-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-6399-9 [68788639909]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-31

NDC 68788-6399-6 [68788639906]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-31

NDC 68788-6399-1 [68788639901]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-31

NDC 68788-6399-3 [68788639903]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-31

NDC 68788-6399-8 [68788639908]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-31

Drug Details

Active Ingredients

IngredientStrength
FAMOTIDINE20 mg/1

OpenFDA Data

SPL SET ID:ae7b5b4d-3b6a-45ae-b394-a4480d072715
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310273

    • Pharmacological Class

    • Histamine H2 Receptor Antagonists [MoA]
    • Histamine-2 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "Famotidine" or generic name "Famotidine"

    NDCBrand NameGeneric Name
    0093-2748FamotidineFamotidine
    0172-5728FamotidineFamotidine
    0172-5729FamotidineFamotidine
    0338-5197FamotidineFamotidine
    0363-0036FamotidineFamotidine
    0363-1899FamotidineFamotidine
    68001-240FamotidineFamotidine
    68001-241FamotidineFamotidine
    68071-1879FamotidineFamotidine
    68071-3181FamotidineFamotidine
    68071-1941FamotidineFamotidine
    68071-3305FamotidineFamotidine
    68071-4197FamotidineFamotidine
    68071-3201FamotidineFamotidine
    68151-0184FamotidineFamotidine
    68151-0185FamotidineFamotidine
    68180-150FamotidineFamotidine
    68210-0007FAMOTIDINEFAMOTIDINE
    68382-444FamotidineFamotidine
    68645-140FamotidineFamotidine
    68645-141FamotidineFamotidine
    68788-6859FamotidineFamotidine
    68788-6399FamotidineFamotidine
    68788-9217FamotidineFamotidine
    68788-7191FamotidineFamotidine
    68788-9549FamotidineFamotidine
    68788-9220FamotidineFamotidine
    68788-9779FamotidineFamotidine
    70253-128FamotidineFamotidine
    70518-0460FamotidineFamotidine
    70518-0461FamotidineFamotidine
    70518-0163FamotidineFamotidine
    70518-1415FamotidineFamotidine
    70518-1341FamotidineFamotidine
    70518-1001FamotidineFamotidine
    70518-1089FamotidineFamotidine
    70518-1877FamotidineFamotidine
    71335-0409FamotidineFamotidine
    0615-4582FamotidineFamotidine
    71335-0370FamotidineFamotidine
    0615-4594FamotidineFamotidine
    72036-026FamotidineFamotidine
    0641-6023FamotidineFamotidine
    0641-6022FamotidineFamotidine
    0641-6021FamotidineFamotidine
    10544-481FamotidineFamotidine
    12634-967FamotidineFamotidine
    15127-370FamotidineFamotidine
    33261-185FamotidineFamotidine
    33261-562FamotidineFamotidine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.